We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s drug pricing watchdog is recommending NHS reimburse for Servier’s metastatic colorectal cancer drug Lonsurf, provided the company offers the drug at a discounted price.